[e-drug] Minilab project now by the Global Pharma Health Fund

[Gphf@aol.com]

E-DRUG: Minilab project now by the Global Pharma Health Fund
------------------------------------------------------------

[Response to message posted June 5 on oseltamivir]

Dear Mr. Kitutu,

I must say you have been wrongly informed about the future of the Minilab 
project: it is by far not dead. In fact, it is more lively than ever before. I am wondering who is disseminating such a nonsense.

>From next month onward, the Minilab project will be operated by the Global 
Pharma Health Fund (new GPHF), a charitable organisation initiated and 
maintained by Merck KGaA*.

Apart from a new name and sponsorship, there will be no changes whatsoever. 
All contact details including email and homepage address will stay the same and I will continue to manage the project as succesfully as in the past.

More information about the new GPHF set up will be formally issued to all our project partners onset next month.

I look forward to receiving continuous support from existing and new project partners.

Yours sincerely

Richard Jähnke
Project Management

German/Global Pharma Health Fund e.V.
Walther-von-Cronberg Platz 6, 
60594 Frankfurt, Germany, 
www.gphf.org
Head Office: T: +49-69-96238760-0, F: +49-69-96238760-9, info@gphf.org
Project Office: T: +49-69-46939-662, F: +49-69-46939-852, 
richard.jaehnke@gphf.org

The new GPHF is a charitable organisation initiated by Merck KGaA*

* Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped about 35,000 employees (including Merck Serono) in 56 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.